Whether ratios of proinsulin intermediates to fully processed insulin might be indicative of diabetes subsets, severity or prognosis is an open question for precision approaches to diabetes diagnosis and management, which we hope the newly established method will help to address. This evidence concerns the gene INS and diabetes mellitus.